Background
Results
Foxp3 + Treg and Th17 cell differentiation factor levels in the HBV infected patients
Peripheral blood Foxp3 + Treg and Th17 cells levels and their effectors
Relationship between Th17 population and liver injury in acute and chroinc HBV infection
Discussion
Conclusion
Methods
Patients
Normal control | HBV carrier | AHB | CHB | ACHBLF | |
---|---|---|---|---|---|
Number
| 10 | 12 | 10 | 18 | 18 |
Age (years)
| 30 (24 ~ 42) | 25(22 ~ 34) | 40 (32 ~ 45) | 37 (21 ~ 68) | 45 (30 ~ 65) |
Gender(male/female)
| 7/3 | 8/4 | 8/2 | 14/4 | 14/4 |
HBeAg positive
| NA | 12 | 2 | 11 | 7 |
HBV DNA
| |||||
(Log
10
IU/mL)
| NA | 8.3(7.24‒9.72) | 3.00(2‒3.12) | 5.15(2.12‒6.73) | 4.53(2.94‒7.14) |
ALT(IU/L)
| NA | 23.5(13‒42) | 915(67‒1226) | 126(65‒988) | 125(21‒1002) |
TBil (μmol/L)
| NA | 10.5(5‒16) | 111(60‒210) | 18.8(8.9‒151) | 457.2(170‒599) |
Encephalopathy grade III/IV(%)
| NA | 0 | 0 | 0 | 35.29 |
Ascites(%)
| NA | 0 | 0 | 0 | 82.35 |
Mortality (%)
| NA | 0 | 0 | 0 | 23.53 |